“Blockage of TGF-β1-induced epithelial-tomesenchymal transition by oxymatrine prevents renal interstitial fibrosis” (2022) Brazilian Journal of Pharmaceutical Sciences, 58. doi:10.1590/s2175-97902020000118738.